Your browser doesn't support javascript.
loading
Response to: Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate.
Wang, Yimin; Han, Hedong; Zhang, Fang; Lv, Tangfeng; Zhan, Ping; Ye, Mingxiang; Song, Yong; Liu, Hongbing.
Afiliación
  • Wang Y; Department of Respiratory Medicine, Jinling Hospital, Nanjing Medical University, Nanjing, China.
  • Han H; Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
  • Zhang F; Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
  • Lv T; Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
  • Zhan P; Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
  • Ye M; Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
  • Song Y; Department of Respiratory Medicine, Jinling Hospital, Nanjing Medical University, Nanjing, China. yong.song@nju.edu.cn.
  • Liu H; Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China. yong.song@nju.edu.cn.
Br J Cancer ; 127(8): 1383-1384, 2022 11.
Article en En | MEDLINE | ID: mdl-36064586

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Br J Cancer Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Br J Cancer Año: 2022 Tipo del documento: Article País de afiliación: China